Shandong Weigao Orthopaedic Device Co., Ltd. Class A

As of June 30, 2026, Shandong Weigao Orthopaedic Device Co., Ltd. Class A carries a market capitalization of 8.39B, placing it among publicly traded companies globally. Its enterprise value stands at 6.99B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Shandong Weigao Orthopaedic Device Co., Ltd. Class A's next confirmed earnings release is scheduled for October 31, 2026.

As of June 30, 2026, Shandong Weigao Orthopaedic Device Co., Ltd. Class A has 400.00M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Shandong Weigao Orthopaedic Device Co., Ltd. Class A maintains a current ratio of 4.32, meaning it holds 4.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Shandong Weigao Orthopaedic Device Co., Ltd. Class A recorded 37.59M in income tax expense.

As of the close on October 22, 2026, Shandong Weigao Orthopaedic Device Co., Ltd. Class A's stock has declined approximately 27.46% over the past 52 weeks. The 50-day moving average sits at 21.98, while the 200-day moving average is 25.89.

As of June 30, 2026, Shandong Weigao Orthopaedic Device Co., Ltd. Class A holds 1.48B in cash and equivalents against 39.61M in total debt, resulting in a net debt position of -1.03B. Total book value stands at 4.20B, with working capital of 3.08B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Shandong Weigao Orthopaedic Device Co., Ltd. Class A paid dividends of 0.30 per share.